Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T-Cell Exhaustion in Dysgerminoma

Miya Nakashima1,2, Takeshi Iwasaki1, Yoshihiro Katayama2

  • 1Departments of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Cancer Science
|November 26, 2025
PubMed

Insights

Malignant ovarian germ cell tumors have distinct tumor microenvironments. Dysgerminomas are immunologically active but may resist therapy due to lost Major Histocompatibility Complex class I expression, impacting T-cell responses.

Area of Science:

  • Oncology
  • Immunology
  • Gynecologic Pathology

Background:

  • Malignant ovarian germ cell tumors (OGCTs) primarily affect young women and, while chemotherapy-responsive, pose long-term adverse effect concerns.
  • Understanding the tumor microenvironment (TME) is crucial for developing alternative therapeutic strategies for rare OGCTs.
  • Comprehensive TME analyses in OGCT subtypes remain limited.

Purpose of the Study:

  • To characterize the distinct tumor microenvironments of major malignant ovarian germ cell tumor subtypes.
  • To evaluate immune cell infiltration, immune checkpoint molecule expression, and immune-related gene expression across OGCT subtypes.
  • To assess the potential impact of TME characteristics on therapeutic responses.

Main Methods:

  • Analysis of 56 malignant ovarian germ cell tumor samples (23 dysgerminomas, 14 yolk sac tumors, 19 immature teratomas).
  • Immunohistochemistry for immune cell infiltration and immune checkpoint molecule expression.
  • Transcriptomic profiling for immune-related gene expression.
  • Multiplex immunofluorescence for T-cell exhaustion assessment in dysgerminomas.
  • Evaluation of Major Histocompatibility Complex class I expression across all subtypes.

Main Results:

  • Dysgerminomas exhibited an immunologically "hot" TME with abundant T-cells, B-cells, M1 macrophages, and tertiary lymphoid structures, alongside upregulated immune checkpoints.
  • Yolk sac tumors were characterized by M2 macrophage dominance, while immature teratomas showed minimal immune infiltration (a "cold" TME).
  • All OGCT subtypes displayed a loss of Major Histocompatibility Complex class I expression, potentially impairing T-cell recognition and antigen presentation.

Conclusions:

  • Malignant ovarian germ cell tumor subtypes possess unique tumor microenvironments.
  • Dysgerminomas, despite being immunologically active, may have ineffective T-cell responses due to absent Major Histocompatibility Complex class I expression.
  • Restoring Major Histocompatibility Complex class I expression could be a therapeutic strategy to improve T cell-based immunotherapy efficacy in dysgerminomas.